Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Therapeutics against filovirus infection
John Connor
, Gary Kobinger
,
Gene Olinger
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapeutics against filovirus infection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Medical Intervention
100%
Filovirus Infection
100%
Supportive Care
100%
Medicine
50%
Infection
50%
Pathogen
50%
Filovirus
50%
Host Factor
50%
Clinical Trial Design
50%
Antiviral Drug
50%
Passive Immunization
50%
Treatment Option
50%
Keyphrases
Filovirus
100%
Medical Intervention
66%
Supportive Care
66%
Treatment Options
33%
Effective Approach
33%
Scientific Community
33%
Direct Antivirals
33%
Efficacy Testing
33%
Safety Testing
33%
Infected Patients
33%
Do No Harm
33%
Passive Immunity
33%
Medical Community
33%
Clinical Trial Design
33%
Tenants
33%
Antiviral Host Factors
33%
Pharmacology, Toxicology and Pharmaceutical Science
Filovirus Infection
100%
Infection
50%
Infectious Agent
50%
Antiviral Drug
50%
Filovirus
50%
Host Factor
50%
Clinical Trial Design
50%
efficacy testing
50%